Most Clicked StoriesMore >


Abbott, Medtronic have no plans to pull coronary stents from Indian market

AdvaMed SmartBrief | Feb 23, 2017

Abbott said it will continue marketing its coronary stents in India, contrary to reports that it plans to withdraw its drug-eluting stents and the Absorb resorbable stent after the National Pharmaceutical Pricing Authority ordered a price cap on the devices. Medtronic also said it does not intend to pull devices from the market. MassDevice.com (Boston) (02/22)


$4.33B deal to acquire Abbott unit finalized by J&J

AdvaMed SmartBrief | Feb 28, 2017

Abbott's heart failure device shows more promise in real world

AdvaMed SmartBrief | Feb 27, 2017

India concerned about stent shortage after price cap

AdvaMed SmartBrief | Feb 23, 2017

Stomach acid powers ingestible medical sensor developed by MIT researchers

AdvaMed SmartBrief | Feb 27, 2017

Boston Scientific announces recall of Lotus heart devices

AdvaMed SmartBrief | Feb 24, 2017

Funding round pulls in $38M for Xenex

AdvaMed SmartBrief | Feb 27, 2017

FDA won't do that: Cybersecurity edition

AdvaMed SmartBrief | Feb 28, 2017

Dexcom debuts continuous glucose monitor

AdvaMed SmartBrief | Feb 28, 2017

Abbott opens exchange offer for St. Jude Medical notes

AdvaMed SmartBrief | Feb 22, 2017


Find AdvaMed SmartBrief Issues by Date:



ADVAMED News More >


Start saving with the AdvaMed Purchasing Group

AdvaMed SmartBrief | Mar 01, 2017

The Digital MedTech Conference

AdvaMed SmartBrief | Mar 01, 2017

PMA Submissions Workshop

AdvaMed SmartBrief | Feb 28, 2017

IDE Submissions Workshop

AdvaMed SmartBrief | Feb 27, 2017

510(k) Submissions Workshop

AdvaMed SmartBrief | Feb 24, 2017




Sign up for AdvaMed SmartBrief



Designed specifically for manufacturers of medical devices, health care information systems and diagnostic products, AdvaMed SmartBrief is a FREE e-mail newsletter. By providing a summary of the day's most important medical technologies news, AdvaMed SmartBrief saves you time and keeps you smart. Learn more

Recent Poll view more polls


What concerns should medical device companies focus on in the coming year?

Chart.